ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

‘Epigenetic CRISPR’ edits DNA without cutting it | FierceBiotech – FierceBiotech

Continue reading

2017-12-08 Michael Zand NEWS

Physical therapy essential to Andrews Institute’s stem cell knee cartilage trial — 3 insights – Becker’s Orthopedic & Spine


FierceBiotech

‘Epigenetic CRISPR’ edits DNA without cutting it | FierceBiotech
FierceBiotech
A Salk Institute team created a form of CRISPR/Cas9 that activates specific genes without making breaks in the DNA, which can cut down on harmful side effects.
CRISPR/Cas9 can reverse multiple diseases in miceScience News
Diabetes and muscular dystrophy could be treated effectively with modified Crispr genetic engineering techniqueThe Independent
CRISPR/Cas9 Edits Epigenome with Therapeutic EfficiencyGenetic Engineering & Biotechnology News

all 52 news articles »

Continue reading

2017-12-08 Michael Zand NEWS

DNA Is Going Digital – What Could Possibly Go Wrong? – 5newsonline.com

Physical therapy essential to Andrews Institute’s stem cell knee cartilage trial — 3 insights
Becker’s Orthopedic & Spine
Physical therapy is playing an important role in a clinical trial being conducted at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics & Sports Medicine, where stem cells are being used to regenerate knee cartilage. Here’s what you should know …

Continue reading

2017-12-08 Michael Zand NEWS

Expert Discusses Promise of CMB305 Immunotherapy Regimen in Sarcoma – Targeted Oncology

Targeted OncologyExpert Discusses Promise of CMB305 Immunotherapy Regimen in SarcomaTargeted OncologyCMB305, an immunotherapy regimen that generates and expands anti–NY-ESO-1 T cells, demonstrated a favorable survival rate compared with other approved … Continue reading

2017-12-08 Michael Zand NEWS

Common virus may help inform treatment planning for stem cell transplant patients – Science Daily

Common virus may help inform treatment planning for stem cell transplant patientsScience DailyThis new finding is the latest in a line of research led by physician-scientist, Amir Toor, M.D. Toor and his colleagues have been working to create computer … Continue reading

2017-12-08 Michael Zand NEWS

Gene therapy shows promise against blood-clotting disease – Coos Bay World


5newsonline.com

DNA Is Going Digital – What Could Possibly Go Wrong?
5newsonline.com
We’ve even hosted FBI agents from the Weapons of Mass Destruction Directorate here at Colorado State University and previously at Virginia Tech for crash courses on synthetic biology and the associated cyberbiosecurity risks. A year ago, we …

and more »

Continue reading

2017-12-08 Michael Zand NEWS

CRISPR Therapeutics: Analysis Of And Update On The B-Thalassemia Franchise – Seeking Alpha


Coos Bay World

Gene therapy shows promise against blood-clotting disease
Coos Bay World
The therapy supplies the missing gene, using a virus that’s been modified so it won’t cause illness but ferries the DNA instructions to liver cells, which use them to make the clotting factor. The treatment is given through an IV. In a study published …

and more »

Continue reading

2017-12-08 Michael Zand NEWS

Novel harvesting method rapidly produces superior stem cells for transplantation – Science Daily

Novel harvesting method rapidly produces superior stem cells for transplantationScience DailyA new method of harvesting stem cells for bone marrow transplantation — developed by a team of investigators from the Massachusetts General Hospital (MGH) Can… Continue reading

2017-12-08 Michael Zand NEWS
  • 1
  • …
  • 813
  • 814
  • 815
  • 816
  • 817
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Seeking Alpha

CRISPR Therapeutics: Analysis Of And Update On The B-Thalassemia Franchise
Seeking Alpha
The company recently submitted a CTA for CTX-001 (the potential treatment for the blood disorder Beta-thalassemia). It’s the first application for the CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a potentially revolutionary platform to launch a …